期刊文献+

冠心病患者无症状心肌缺血阈的临床意义

Chinical significance of myocardial ischemic threshold in silent myocardial ischemic patients with coronary heart disease
暂未订购
导出
摘要 目的:探讨冠心病患者无症状心肌缺血阈(MIT)的临床应用价值。方法:记录73例冠心病患者十二导联动态心电图的MIT及其变异性(IV)、每次缺血发作持续时间(Tmi)和ST段最大位移(STm)以及昼夜缺血次数。结果:73例冠心病患者中共检出心肌缺血650次,其中600次属无症状心肌缺血,92.8%在ST段压低时心率加快,夜间MIT值较低,但缺血时间及ST段压低程度明显重于昼间(P<0.01)。结论:十二导联动态心电图是临床上检测无症状心肌缺血(SMI)的重要方法之一,对临床评估SMI的预后及给药有重要临床意义。 Objective:To investigate the clinical value of myocardial ischemic thresold (MIT) in silent myocardial ischemia (SMI) patients with CHD.Methods:Using 12-lead dynamic electrocardiography (DCG) to monitor MIT, IV ,Taft, STm ,day and night ischemie episodes in 73 CHD patients.Results:Isehemic episodes were 650 times,600 of them belonged to SMI,92.8% of them had the faster heart rate when ST depression;MIT in night was lower, but TMI and STm were higher than those in day (P〈0.01).Conclusion:Using 12-lead. DCG to monitor SMI is one of the important methods and has clinical significance to evaluate the prognosis and treatment effects of SMI patients with CHD.
出处 《现代医药卫生》 2009年第18期2755-2756,共2页 Journal of Modern Medicine & Health
关键词 冠心病 无症状心肌缺血 心肌缺血阈 十二导联动态心电图 Coronary heat disease Silent myocardial isehemia Myoeardieal ischemie threshold 12-lead dynamic electrocardiography
  • 相关文献

参考文献2

二级参考文献23

  • 1韩燕 诸骏仁.无症状心肌缺血阈的临床意义及诊断[J].国外医学:心血管疾病分册,1988,15:65-65.
  • 2Tzivoni D,Gavish A,Benhorin J.Day to day variability of mycardialischemic eoisodes in coronary artery disease. Am J cardial, 1987,60:100.
  • 3Figueras J, Cinca J, Baida F. Resting angina with fixed coronary artery stenosis: Noctrural decline inischemic threshold. Circ, 1986,74:1248
  • 4Behar S,Reicher H,Goldbourt U. Circadian variation in pain onset i nunstable angina pectoris. Am J cardiol, 1991,67:91
  • 5Gibbons R J, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation,2003,107 : 149-158.
  • 6Eme P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI Ⅱ randomized controlled trial. JAMA, 2007,297 : 1985 -1991.
  • 7Hanssen GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med,2005,352:1685-1695.
  • 8Morrow DA, de Lemos JA, Sabatine MS, et al. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation, 2006,114:281-288.
  • 9Crawford MH, Bemstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography ). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol,1999,34:912-948.
  • 10Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol, 2002, 39:257-265.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部